Excellence in Oncology Care (EIOC) shared a post on LinkedIn:
“Join us for an expert-led discussion at the EIOC Journal Club as we delve into Mastering the Sequencing in HR+ve HER2-negative aBC Patients with AKT Mutation (Post SABCS 2025 Updates).
We’re honored to have Dr. Carlos Barrios, Co-Founder and Current Director of LACOG- Latin American Cooperative Oncology Group, share his insights on the evolving strategies in managing HR+ HER2-negative advanced breast cancer.
This session is complimentary for practicing healthcare professionals.
Date: 18 December 2025
Time: 19:00 – 20:30 UAE Time
Register here.
Complimentary Registration for Healthcare Professionals.”
More posts featuring EIOC on OncoDaily.